UGenDx is developing URODYNE™, an automated point-of-detection platform designed to enrich and preserve urinary cells for downstream cytology and molecular analysis.
Initial focus on urine cytology and bladder-cancer pathways, with longer-term potential across urine-based applications.
TECHNOLOGY & IP
Built on a protected foundation.
Foundational urine-filtration technology originating from an EU Horizon 2020-supported programme, now being advanced into a new automated medical-device platform.